coronary heart disease
CRN Responds to Cholesterol Study That Compares Supplements to Prescription Drug
The Council for Responsible Nutrition (CRN) has responded to results of the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study. It was presented at the American Heart Association Scientific Sessions Nov. 6 and published in the Journal of the American College of Cardiology. SPORT, funded by AstraZeneca, the company that markets Rosuvastatin, compared the effect on low-density ...
Meta-Analysis Validates Cardiovascular Benefit of Omega-3 EFA Consumption
A newly published meta-analysis sought to reveal whether marine omega‐3 supplementation is associated with reduction in risk of cardiovascular disease (CVD). The study team included data from 13 trials. They specifically looked at rates of myocardial infarction, coronary heart disease (CHD) death, total CHD, total stroke, CVD death, total CVD and major vascular events. They ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
